Allergens abrogate antiinflammatory DNA effects and unmask macrophage-driven neutrophilic asthma via ILC2/STING/TNF-α signaling
The mechanisms of neutrophilic and mixed neutrophilic-eosinophilic asthma are poorly understood. We found that extracellular DNA and nucleosomes (Nucs) were elevated in the airways of patients with neutrophilic-eosinophilic asthma and correlated with bronchoalveolar lavage neutrophils. Bronchial tissue from neutrophilic-eosinophilic asthma had more DNA sensor-positive cells. Intranasally administered DNA did not induce airway hyperreactivity (AHR) or any pathology but induced AHR and neutrophilic-eosinophilic inflammation when coadministered with the allergen Alternaria (Alt). Nuc alone induced antiinflammatory/defensive genes, whereas the Nuc-Alt combination increased levels of TNF-α and innate cytokines. The Alt-Nuc phenotype was abolished in Cgas-/-, ALR-/-, Sting-/-, LysMCre:Stingfl/fl, IL7RCre:Rorαfl/fl, and Tnfr2-/- mice. Alt, unexpectedly, played an essential role in the Nuc-induced phenotype. It abrogated Nuc induction of antiinflammatory genes, facilitated Nuc uptake, induced type 2 innate lymphoid cells, which, in the presence of Nuc, produced high levels of TNF-α, and promoted neutrophilic infiltration. We established a paradigm whereby allergens inhibit the antiinflammatory effects of DNA/Nuc and facilitate STING-TNF-α-driven neutrophilic-eosinophilic inflammation in asthma.
Authors
- Carolyn Kwiat
- Mukesh Verma (ORCID: https://orcid.org/0000-0002-1817-0863)
- Anita Sahu (ORCID: https://orcid.org/0000-0001-9552-922X)
- Andrew Getahun (ORCID: https://orcid.org/0000-0002-5663-6812)
- Brian Vestal (ORCID: https://orcid.org/0000-0002-3772-1691)
- Mohini Pathria
- Camille M. Moore (ORCID: https://orcid.org/0000-0002-7363-8684)
- John C. Cambier (ORCID: https://orcid.org/0000-0002-7803-242X)
- Vamsi P. Guntur (ORCID: https://orcid.org/0000-0002-3210-8265)
- Rangati Varma (ORCID: https://orcid.org/0000-0003-1813-3285)
- Kapil Sirohi (ORCID: https://orcid.org/0000-0001-5039-2848)
- Divya Verma (ORCID: https://orcid.org/0000-0002-0746-6642)
- Laurie A. Manka (ORCID: https://orcid.org/0000-0003-4839-7812)
- Magdalena M. Gorska (ORCID: https://orcid.org/0000-0001-7364-8703)
- Richard J. Martin (ORCID: https://orcid.org/0000-0003-2478-5239)
- Anand Sripada (ORCID: https://orcid.org/0000-0002-5163-6637)
- Rafeul Alam
Institutions
- University of Denver (US)
- National Jewish Health (US)
- National Institute of Allergy and Infectious Diseases (US)
- University of Colorado Denver (US)
Publication Details
- Journal
- Journal of Clinical Investigation
- Published
- 2025-06-17
- DOI
- https://doi.org/10.1172/jci187907
- Citations
- 1
- Primary Topic
- IL-33, ST2, and ILC Pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.80
Funders
- National Institutes of Health